VRCHIVADV014-00-VP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VRCHIVADV014-00-VP, covering 2021-10-15 to 2021-10-15. Get the full timeline:
Most recent: Clinical Trial Update: HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants [Phase 2]